Crossmark

Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling

Published Online: 2021-03-01

Published Print: 2021-06

Authors

Gupta, Nidhi

Kumar, Raman

Sharma, Alpana https://orcid.org/0000-0001-7761-5511
Funding

Funding for this research was provided by:

Council of Scientfic and Industrial Research (09/006(0451)/2015-EMR-I)

All India Institute of Medical Sciences (A-489)
License Information

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2021-03-01
More Information

Article History

Received: 13 September 2020

Accepted: 22 December 2020

First Online: 1 March 2021

Compliance with ethical standards

:

: There is no conflict of interest among authors.

Document is current